Detailed information for compound 1538853

Basic information

Technical information
  • TDR Targets ID: 1538853
  • Name: 38040-79-8
  • MW: 254.714 | Formula: C15H11ClN2
  • H donors: 0 H acceptors: 0 LogP: 2.96 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc2c(c1)c1ccccc1c1=NCCn21
  • InChi: 1S/C15H11ClN2/c16-10-5-6-14-13(9-10)11-3-1-2-4-12(11)15-17-7-8-18(14)15/h1-6,9H,7-8H2
  • InChiKey: KMDWKSYBWOTXEV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • Imidazo[1,2-f]phenanthridine, 7-chloro-2,3-dihydro-
  • NSC141591

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glycoprotein hormones, alpha polypeptide Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens isocitrate dehydrogenase 1 (NADP+), soluble Starlite/ChEMBL No references
Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 Starlite/ChEMBL No references
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium knowlesi isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans DNA helicase Get druggable targets OG5_127595 All targets in OG5_127595
Loa Loa (eye worm) BRM protein Get druggable targets OG5_127595 All targets in OG5_127595
Neospora caninum SNF2 family N-terminal domain-containing protein (EC 2.7.11.1), related Get druggable targets OG5_127595 All targets in OG5_127595
Neospora caninum hypothetical protein Get druggable targets OG5_127595 All targets in OG5_127595
Trypanosoma congolense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium berghei isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Toxoplasma gondii SWI2/SNF2 Brahma-like putative Get druggable targets OG5_127595 All targets in OG5_127595
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) Get druggable targets OG5_127057 All targets in OG5_127057
Babesia bovis isocitrate dehydrogenase, NADP-dependent family protein Get druggable targets OG5_127057 All targets in OG5_127057
Toxoplasma gondii isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans transcriptional regulator Get druggable targets OG5_127595 All targets in OG5_127595
Trypanosoma brucei gambiense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma cruzi isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Toxoplasma gondii isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma mansoni helicase Get druggable targets OG5_127595 All targets in OG5_127595
Cryptosporidium parvum brahma like protein with a HSA domain, SNF2 like helicase and a bromo domain Get druggable targets OG5_127595 All targets in OG5_127595
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Neospora caninum Isocitrate dehydrogenase-like protein, related Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma brucei isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania braziliensis isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Trichomonas vaginalis lymphoid specific helicase, putative Get druggable targets OG5_127595 All targets in OG5_127595
Cryptosporidium parvum SWI/SNF related putative transcriptional regulator ATpase Get druggable targets OG5_127595 All targets in OG5_127595
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans N terminus of cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma congolense isocitrate dehydrogenase, putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma japonicum ko:K01529 SMARCA2, SNF2L2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [EC Get druggable targets OG5_127595 All targets in OG5_127595
Leishmania donovani isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Brugia malayi BRM protein Get druggable targets OG5_127595 All targets in OG5_127595
Candida albicans DNA helicase Get druggable targets OG5_127595 All targets in OG5_127595
Echinococcus multilocularis global transcription activator snf2l2 Get druggable targets OG5_127595 All targets in OG5_127595
Plasmodium yoelii isocitrate dehydrogenase, NADP-dependent, putative Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus granulosus global transcription activator snf2l2 Get druggable targets OG5_127595 All targets in OG5_127595
Plasmodium yoelii isocitrate dehydrogenase, NADP-dependent Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans transcriptional regulator Get druggable targets OG5_127595 All targets in OG5_127595
Plasmodium knowlesi DEAD/DEAH helicase, putative Get druggable targets OG5_127595 All targets in OG5_127595
Schistosoma japonicum Homeotic gene regulator, putative Get druggable targets OG5_127595 All targets in OG5_127595
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans C terminus of cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Trypanosoma brucei gambiense isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium vivax DEAD/DEAH helicase, putative Get druggable targets OG5_127595 All targets in OG5_127595
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Loa Loa (eye worm) isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Loa Loa (eye worm) BRM protein Get druggable targets OG5_127595 All targets in OG5_127595
Toxoplasma gondii SWI2/SNF2 Brahma-like putative Get druggable targets OG5_127595 All targets in OG5_127595
Candida albicans Mitochondrial NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Theileria parva isocitrate dehydrogenase (NADP+), putative Get druggable targets OG5_127057 All targets in OG5_127057
Schistosoma japonicum ko:K00031 isocitrate dehydrogenase [EC1.1.1.42], putative Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative Get druggable targets OG5_127057 All targets in OG5_127057
Echinococcus granulosus NADP dependent isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Brugia malayi Isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium berghei DEAD/DEAH helicase, putative Get druggable targets OG5_127595 All targets in OG5_127595
Leishmania infantum isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium falciparum DEAD/DEAH box helicase, putative Get druggable targets OG5_127595 All targets in OG5_127595
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans cytosolic NADP-specific isocitrate dehydrogenase. Get druggable targets OG5_127057 All targets in OG5_127057
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) Get druggable targets OG5_127057 All targets in OG5_127057
Leishmania mexicana isocitrate dehydrogenase [NADP], mitochondrial precursor, putative Get druggable targets OG5_127057 All targets in OG5_127057
Brugia malayi isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Candida albicans Mitochondrial NADP-specific isocitrate dehydrogenase Get druggable targets OG5_127057 All targets in OG5_127057
Neospora caninum hypothetical protein Get druggable targets OG5_127057 All targets in OG5_127057
Plasmodium yoelii Arabidopsis thaliana BRAHMA ortholog-related Get druggable targets OG5_127595 All targets in OG5_127595
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Toxoplasma gondii intraflagellar transport protein 172, putative glycoprotein hormones, alpha polypeptide 116 aa 94 aa 26.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.2489 1
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0019 0.08 0.08
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0019 0.08 0.08
Brugia malayi Latrophilin receptor protein 2 0.0019 0.08 0.0747
Echinococcus multilocularis chromodomain helicase DNA binding protein 7 0.0014 0.0057 0.0057
Loa Loa (eye worm) cytochrome P450 family protein 0.0026 0.1799 0.2545
Loa Loa (eye worm) hypothetical protein 0.0019 0.08 0.1085
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.6901 0.6883
Schistosoma mansoni helicase 0.0081 1 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.4077 0.5874
Echinococcus multilocularis Chromo domain 0.0014 0.0057 0.0057
Trypanosoma brucei cytochrome P450, putative 0.0026 0.1799 0.5904
Brugia malayi Cytochrome P450 family protein 0.0026 0.1799 0.1751
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.6901 0.6883
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0805 0.0805
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0019 0.08 0.08
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0019 0.08 0.08
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0019 0.08 0.0747
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0805 0.0805
Loa Loa (eye worm) hypothetical protein 0.0018 0.0699 0.0938
Brugia malayi Cytochrome P450 family protein 0.0026 0.1799 0.1751
Loa Loa (eye worm) hypothetical protein 0.006 0.6901 1
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Trypanosoma cruzi cytochrome P450, putative 0.0026 0.1799 0.5904
Loa Loa (eye worm) hypothetical protein 0.003 0.2489 0.3553
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.4077 0.4043
Schistosoma mansoni hypothetical protein 0.0019 0.08 0.08
Trypanosoma cruzi cytochrome P450, putative 0.0026 0.1799 0.5904
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.2489 1
Loa Loa (eye worm) CYP4Cod1 0.0026 0.1799 0.2545
Schistosoma mansoni hypothetical protein 0.0019 0.08 0.08
Brugia malayi hypothetical protein 0.002 0.0889 0.0837
Echinococcus granulosus BRK domain containing protein 0.0014 0.0057 0.0057
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.2489 1
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Loa Loa (eye worm) BRM protein 0.0052 0.5655 0.8179
Echinococcus multilocularis GPCR, family 2 0.0019 0.08 0.08
Echinococcus granulosus Chromo domain 0.0014 0.0057 0.0057
Brugia malayi isocitrate dehydrogenase 0.0019 0.0805 0.0751
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.2489 1
Schistosoma mansoni hypothetical protein 0.0041 0.4077 0.4077
Leishmania major hypothetical protein, conserved 0.003 0.2489 1
Echinococcus granulosus global transcription activator snf2l2 0.0081 1 1
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.0026 0.1799 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.0026 0.1799 0.2545
Schistosoma mansoni hypothetical protein 0.0019 0.08 0.08
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0019 0.0805 0.0805
Schistosoma mansoni hypothetical protein 0.0019 0.08 0.08
Loa Loa (eye worm) BRM protein 0.0042 0.4193 0.6043
Loa Loa (eye worm) latrophilin receptor protein 2 0.0019 0.08 0.1085
Toxoplasma gondii LsmAD domain-containing protein 0.003 0.2489 1
Schistosoma mansoni hypothetical protein 0.0014 0.0057 0.0057
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0805 0.0805
Leishmania major cytochrome p450-like protein 0.0026 0.1799 0.5904
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.2489 1
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.0019 0.0805 0.0805
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Brugia malayi Isocitrate dehydrogenase 0.0019 0.0805 0.0751
Schistosoma mansoni hypothetical protein 0.0014 0.0057 0.0057
Echinococcus multilocularis isocitrate dehydrogenase 0.0019 0.0805 0.0805
Loa Loa (eye worm) isocitrate dehydrogenase 0.0019 0.0805 0.1092
Trichomonas vaginalis lymphoid specific helicase, putative 0.0015 0.0166 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.6901 1
Toxoplasma gondii isocitrate dehydrogenase 0.0019 0.0805 0.275
Echinococcus multilocularis global transcription activator snf2l2 0.0081 1 1
Brugia malayi hypothetical protein 0.003 0.2489 0.2445
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.0019 0.0805 0.0805
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0019 0.0805 0.5
Echinococcus multilocularis BRK domain containing protein 0.0014 0.0057 0.0057
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.2489 1
Toxoplasma gondii isocitrate dehydrogenase 0.0019 0.0805 0.275
Echinococcus granulosus GPCR family 2 0.0019 0.08 0.08
Echinococcus multilocularis BRK domain 0.0014 0.0057 0.0057

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 4.651 uM PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM). (Class of assay: confirmatory) ChEMBL. No reference
EC50 (functional) > 59.516 uM PUBCHEM_BIOASSAY: Luminescence-based cell-based high throughput dose response assay for activators of the GAA850 frataxin (FXN) promoter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540364, AID588328, AID588350, AID588351] ChEMBL. No reference
EC50 (functional) > 59.516 uM PUBCHEM_BIOASSAY: Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput dose response assay to identify activators of the GAA30 frataxin promoter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540364, AID588328, AID588350, AID588351] ChEMBL. No reference
IC50 (binding) 43.795 uM PubChem BioAssay. Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical high throughput dose response assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 0.0631 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 1.9953 uM PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 3.9811 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 18.3564 uM PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 22.3872 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.